(82 intermediate revisions by the same user not shown) | |||
Line 52: | Line 52: | ||
vertical-align: middle; | vertical-align: middle; | ||
} | } | ||
− | + | #top_menu_inside .submenu{min-height:250px;} | |
#abstract{ | #abstract{ | ||
− | background-color: rgba( | + | background-color: rgba(147,251,152,0.9); |
position: fixed; | position: fixed; | ||
− | margin: | + | margin: 1.25em 20em 0 20em; |
height: 90%; | height: 90%; | ||
z-index:-1; | z-index:-1; | ||
+ | font-family:'Comic Sans MS','Arial Black'; | ||
+ | display: none; | ||
+ | border:solid 1px white; | ||
+ | |||
} | } | ||
#scroll_to_bottom{ | #scroll_to_bottom{ | ||
− | |||
position: fixed; | position: fixed; | ||
− | |||
text-align: center; | text-align: center; | ||
color: #ffffff; | color: #ffffff; | ||
font-weight: bold; | font-weight: bold; | ||
+ | bottom: 10%; | ||
+ | left: 40%; | ||
} | } | ||
− | @media screen and (max-width: | + | @media screen and (max-width: 1170px) { |
.menu{ | .menu{ | ||
display: none; | display: none; | ||
− | |||
} | } | ||
Line 83: | Line 86: | ||
} | } | ||
+ | @media screen and (max-width: 980px){ | ||
+ | #ClickBack{ | ||
+ | display: none; | ||
+ | } | ||
+ | #abstract{ | ||
+ | background-color: rgba(147,251,152,0.9); | ||
+ | position: fixed; | ||
+ | margin: 45% auto 0 auto; | ||
+ | min-height: 40em; | ||
+ | height:auto; | ||
+ | z-index:-1; | ||
+ | font-family:'Comic Sans MS','Arial Black'; | ||
+ | border:solid 1px white; | ||
+ | display: block; | ||
+ | overflow:hidden; | ||
+ | } | ||
+ | #scroll_to_bottom{ | ||
+ | display: none; | ||
+ | } | ||
+ | body{ | ||
+ | background-color: white; | ||
+ | } | ||
+ | .menu{ | ||
+ | display: none; | ||
+ | } | ||
− | @media screen and (min-width: | + | .container { |
+ | display: block; | ||
+ | } | ||
+ | } | ||
+ | @media screen and (min-width: 1170px) { | ||
.menu{ | .menu{ | ||
Line 95: | Line 127: | ||
} | } | ||
− | + | ||
− | + | #abstract #guanjian {margin-left:7em;font-family:'Comic Sans MS','Arial Black';font-size:16px;} | |
− | font- | + | p{ |
+ | margin-left: 5em; | ||
+ | margin-right: 5em; | ||
+ | font-family:'Comic Sans MS','Arial Black'; | ||
} | } | ||
− | h1 | + | h1{ |
− | margin-left: | + | margin-left: 4.5em; |
− | margin-right: | + | margin-right: 5em; |
− | margin-top: | + | margin-top: 3.5em; |
+ | font-family:'Comic Sans MS','Arial Black'; | ||
} | } | ||
+ | #ClickBack{ | ||
+ | text-align: center; | ||
+ | position: fixed; | ||
+ | bottom: 3em; | ||
+ | right: 18em; | ||
+ | display:none; | ||
+ | font-family:'Comic Sans MS','Arial Black'; | ||
+ | } | ||
+ | |||
+ | #ClickBack img{ | ||
+ | width: 6em; | ||
+ | } | ||
+ | |||
</style> | </style> | ||
Line 121: | Line 170: | ||
$(document).ready(function(){ | $(document).ready(function(){ | ||
− | + | ||
− | + | $("#scroll_to_bottom").click(function(){ | |
− | + | $("#abstract").slideToggle(); | |
− | + | $("#ClickBack").slideToggle(); | |
+ | $("#scroll_to_bottom").slideToggle(); | ||
+ | }); | ||
+ | |||
+ | $("#ClickBack").click(function(){ | ||
+ | $("#abstract").fadeOut("slow"); | ||
+ | $("#ClickBack").fadeOut("slow"); | ||
+ | $("#scroll_to_bottom").fadeIn("slow"); | ||
+ | }); | ||
+ | }); | ||
+ | |||
</script> | </script> | ||
</head> | </head> | ||
− | <body > | + | <body> |
− | + | <!-- small screen menu --> | |
− | + | ||
<div class="container" > | <div class="container" > | ||
<ul id="gn-menu" class="gn-menu-main" > | <ul id="gn-menu" class="gn-menu-main" > | ||
Line 151: | Line 210: | ||
</li> | </li> | ||
<li> | <li> | ||
− | <a href="https://2016.igem.org/Team:NAU-CHINA/ | + | <a href="https://2016.igem.org/Team:NAU-CHINA/Part_Collection"> PARTS</a> |
</li> | </li> | ||
+ | |||
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Safety"> SAFETY</a></li> | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Safety"> SAFETY</a></li> | ||
− | <li><a href="https://2016.igem.org/Team:NAU-CHINA/ | + | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Attributions"> ATTRIBUTION</a></li> |
<li> | <li> | ||
<a href="https://2016.igem.org/Team:NAU-CHINA/Human_Practices"> HP</a> | <a href="https://2016.igem.org/Team:NAU-CHINA/Human_Practices"> HP</a> | ||
Line 169: | Line 229: | ||
− | + | <nav> | |
<!-- big screen menu--> | <!-- big screen menu--> | ||
<div class="nav" id="main" role="main"> | <div class="nav" id="main" role="main"> | ||
Line 177: | Line 237: | ||
<ul class="submenu"> | <ul class="submenu"> | ||
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Participator">Participator</a></li> | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Participator">Participator</a></li> | ||
− | <li><a href="https://2016.igem.org/Team:NAU-CHINA/ | + | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Collaborations">Collaboration</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 183: | Line 243: | ||
<ul class="submenu"> | <ul class="submenu"> | ||
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Description">Description</a></li> | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Description">Description</a></li> | ||
− | <li><a href="https://2016.igem.org/Team:NAU-CHINA/ | + | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Design">Applied Design</a></li> |
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Experiment">Experiment</a></li> | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Experiment">Experiment</a></li> | ||
− | <li><a href="https://2016.igem.org/Team:NAU-CHINA/ | + | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Proof">Proof of Concept</a></li> |
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Demonstrate">Demonstrate </a></li> | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Demonstrate">Demonstrate </a></li> | ||
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Model">Model </a></li> | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Model">Model </a></li> | ||
− | |||
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Notebook">Notebook </a></li> | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Notebook">Notebook </a></li> | ||
</ul> | </ul> | ||
Line 194: | Line 253: | ||
<li><a>PARTS</a> | <li><a>PARTS</a> | ||
<ul class="submenu"> | <ul class="submenu"> | ||
− | <li><a href="https://2016.igem.org/Team:NAU-CHINA/ | + | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Part_List">Part List</a></li> |
− | <li><a href="https://2016.igem.org/Team:NAU-CHINA/ | + | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Basic_Part">Basic Part</a></li> |
− | + | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Composite_Part">Composite Part</a></li> | |
+ | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Part_Collection">Collection</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Safety">SAFETY</a></li> | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Safety">SAFETY</a></li> | ||
− | <li><a href="https://2016.igem.org/Team:NAU-CHINA/ | + | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Attributions">ATTRIBUTION</a></li> |
<li><a>HUMAN PRACTICE</a> | <li><a>HUMAN PRACTICE</a> | ||
<ul class="submenu"> | <ul class="submenu"> | ||
<li><a href="https://2016.igem.org/Team:NAU-CHINA/Human_Practices">Human Practices</a></li> | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Human_Practices">Human Practices</a></li> | ||
− | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Silver">Silver</a></li> | + | <li><a href="https://2016.igem.org/Team:NAU-CHINA/HP/Silver">Silver</a></li> |
− | <li><a href="https://2016.igem.org/Team:NAU-CHINA/Gold">Gold</a></li> | + | <li><a href="https://2016.igem.org/Team:NAU-CHINA/HP/Gold">Gold</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 213: | Line 273: | ||
</nav> | </nav> | ||
<img src="https://static.igem.org/mediawiki/2016/e/e8/NAU_CHINA_2016WIKI_HOME.jpeg" onload="ChangeImg(this)" style="z-index:-60;position:absolute;left:0;top:0px"><!--backgroundimg--> | <img src="https://static.igem.org/mediawiki/2016/e/e8/NAU_CHINA_2016WIKI_HOME.jpeg" onload="ChangeImg(this)" style="z-index:-60;position:absolute;left:0;top:0px"><!--backgroundimg--> | ||
− | + | <div> | |
<div name="abstract" id="abstract"> | <div name="abstract" id="abstract"> | ||
− | <h1>The Birth of Healer & A Story of Us</h1> | + | <br><br> |
− | <p>Several ideas were created and several ideas were denied. Our eyes were blocked by <b style="font-weight: bold;color: | + | <h1 style="font-family:'Comic Sans MS','Arial Black';font-size:20px;">The Birth of Healer & A Story of Us</h1> |
− | <ul>Key words: | + | <p style="font-family:'Comic Sans MS','Arial Black';font-size:17px;">Several ideas were created and several ideas were denied. Our eyes were blocked by <b style="font-weight: bold;color:blue;">3-phenoxybenzoate acid(3-PBA)</b>, the main intermediate product of pyrethroids. But what is 3-PBA and what are pyrethroids? Why we need to degrade 3-PBA thoroughly and how to degrade it through employing microbial biodegradation techniques? Once our Healer (the engineered bacteria) were born, how to put it into practice? From knowing to deep knowing, our efforts made it real.</p><br> |
+ | <ul id="guanjian">Key words: | ||
<li>Cause <span>(what is 3-PBA and what are pyrethroids? Why we need to degrade 3-PBA thoroughly?)</span></li> | <li>Cause <span>(what is 3-PBA and what are pyrethroids? Why we need to degrade 3-PBA thoroughly?)</span></li> | ||
<li>Method <span>(How to degrade it through employing microbial biodegradation techniques?)</span></li> | <li>Method <span>(How to degrade it through employing microbial biodegradation techniques?)</span></li> | ||
<li>Extention <span>(How to put it into practice?)</span></li> | <li>Extention <span>(How to put it into practice?)</span></li> | ||
</ul> | </ul> | ||
− | + | <br><br> | |
</div> | </div> | ||
+ | <br style="clear:both;"></div> | ||
+ | <div id="ClickBack"> | ||
+ | <img src="https://static.igem.org/mediawiki/2016/e/e9/NAU_CHINA_2016_ClickToBack.gif"> | ||
+ | <p>Click Me Back</p> | ||
+ | </div> | ||
<div id="scroll_to_bottom"> | <div id="scroll_to_bottom"> | ||
<p>Click here to see more</p> | <p>Click here to see more</p> | ||
− | + | <img src="https://static.igem.org/mediawiki/2016/6/60/NAU_CHINA_2016_scrollBottom.gif"> | |
</div> | </div> | ||
<script type="text/javascript" src="https://2016.igem.org/Template:NAU-CHINA/modernizr_custom? | <script type="text/javascript" src="https://2016.igem.org/Template:NAU-CHINA/modernizr_custom? |
Latest revision as of 18:17, 19 October 2016
The Birth of Healer & A Story of Us
Several ideas were created and several ideas were denied. Our eyes were blocked by 3-phenoxybenzoate acid(3-PBA), the main intermediate product of pyrethroids. But what is 3-PBA and what are pyrethroids? Why we need to degrade 3-PBA thoroughly and how to degrade it through employing microbial biodegradation techniques? Once our Healer (the engineered bacteria) were born, how to put it into practice? From knowing to deep knowing, our efforts made it real.
- Key words:
- Cause (what is 3-PBA and what are pyrethroids? Why we need to degrade 3-PBA thoroughly?)
- Method (How to degrade it through employing microbial biodegradation techniques?)
- Extention (How to put it into practice?)
Click Me Back
Click here to see more